Xiaodong Health Announced New Strategic Investment

(VCBeat) Mar. 19, 2021 -- Xiaodong Health, the first integrated mental health service platform in China, announced a new round of strategic investment. The investors are from the national alliance of mental and psychological industry. The existing investor Guangzhou Ranxin Pharmaceutical also contributed to the round. The introduction of this strategic investment marks the basic formation of the industrial integration pattern of Xiaodong Health in the field of the mental and psychological segment and lays a solid foundation for Xiaodong Health to develop rapidly, improve sustainable profitability and accelerate the ecological construction in the industry.

It is reported that Xiaodong Health plans to use the funding for the construction of its data-driven system and upgrading of related products.

Xiaodong Health is the first national high-tech enterprise that applies big data and AI technology to the diagnosis and treatment of mental illness in China. At present, it has formed an integrated service platform from online testing, online consultation, re-examination and prescription, drug distribution, out-of-hospital rehabilitation, psychological counseling, medical insurance and psychological big data.

Xiaodong Internet Hospital is the first platform in China to obtain the license of Internet hospitals for psychiatric specialty after the implementation of the Measures for the Administration of Internet Hospitals by the National Health Commission. At the same time, has it has obtained the Internet pharmaceutical information service qualification and the certification of level-3 security protection of information system, which ensures the legitimacy of the doctor's practice, the safety of drug trade, and the privacy of users' information.

The mental illness computer-aided diagnosis system independently developed by Xiaodong Health has been implemented in more than 1,000 medical institutions in China. Its psychological screening and diagnostic tools have been widely used in more than 3,000 military institutions, schools, enterprises and others, with an annual service of nearly ten million people.

At present, Xiaonao Health has the most complete product catalog and drug distribution system for psychosocial diseases in China, including antidepressant and anti-anxiety drugs, mood stabilizers, Chinese patent medicine, auxiliary drugs and others, which can fully meet the medication needs of specialists and patients on its platform.